Indivior plc (INDV) ORD USD0.5

- Add to watchlist
- Create an alert
- This stock can be held in a




Share news, reports & tips
-
Indivior shrinks board following pressure from activist investor
4 March 2025 09:32
(Sharecast News) - Indivior has further overhauled its board, including reducing its size, following pressure from activist investor Oaktree Capital Management.
-
London close: Stocks mixed on corporate earnings, Trump tariff threats
27 February 2025 15:43
(Sharecast News) - London stocks closed in a mixed state on Thursday, with the top-flight index recovering from a weaker open as investors absorbed fresh US jobless claims data and a wave of corporate...
-
Pharma veteran Ciaffoni to take CEO reins at Indivior
27 February 2025 08:37
(Sharecast News) - Indivior announced the appointment of Joe Ciaffoni as its next chief executive officer on Thursday, subject to shareholder approval of a new remuneration policy at its annual general...
-
London close: Stocks slip as US jobless claims rise
20 February 2025 16:06
(Sharecast News) - London equities ended lower on Thursday as investors reacted to a higher-than-expected rise in US jobless claims and a decline in UK consumer confidence.
-
Indivior ends year better than expected, flags tough 2025
20 February 2025 09:09
(Sharecast News) - Shares in Indivior were sliding on Thursday, even after it reported a better-than-expected end to a difficult year, with a 9% increase in full-year 2024 net revenue to $1.19bn amid...
-
London close: Stocks mixed as US inflation comes in hot
12 February 2025 16:59
(Sharecast News) - London stocks closed in a mixed state on Wednesday, as markets reacted to a stronger-than-expected inflation reading from the United States.
-
Indivior flags delay to FDA review of Sublocade label change
12 February 2025 07:24
(Sharecast News) - Indivior announced a delay in the US Food and Drug Administration's (FDA) final review of proposed label changes for its 'Sublocade', or buprenorphine extended-release,...
-
Indivior makes board changes after move to Nasdaq
17 December 2024 10:02
(Sharecast News) - Indivior announced changes to its board of directors on Tuesday, following discussions with Oaktree Capital Management, which advises funds holding a stake in the company.
-
Oaktree Capital calls on Indivior to refresh board of directors
7 November 2024 20:03
(Sharecast News) - Investment fund Oaktree Capital Management has written to Indivior urging the opioid addiction treatment maker to refresh its board with directors "committed to taking all steps...
-
London close: Stocks mixed after barrage of corporate updates
24 October 2024 09:37
(Sharecast News) - London's stock markets ended Thursday with mixed results, with the top-flight index held aloft by strong earnings reports from major companies like Unilever and Barclays, as investors...
-
Indivior confident after strong third quarter
24 October 2024 08:22
(Sharecast News) - Addiction treatment specialist Indivior reported a strong third-quarter performance on Thursday, with total net revenue increasing 13% to $307m compared to the same period last year, after...
-
London close: Stocks red as US inflation, jobless claims top forecasts
10 October 2024 14:58
(Sharecast News) - London's stock markets ended Thursday in negative territory as investors weighed a higher-than-expected inflation and jobless claims readings out of the United States.
Company announcements Announcements
-
Director/PDMR Shareholding
11 March 2025 12:41
Indivior
-
Director/PDMR Shareholding
11 March 2025 10:18
Indivior
-
Director/PDMR Shareholding
10 March 2025 17:39
Indivior
-
Director/PDMR Shareholding
5 March 2025 14:02
Indivior
-
Holding(s) in Company
4 March 2025 13:45
Indivior
-
Director/PDMR Shareholding
4 March 2025 11:23
Indivior
-
Holding(s) in Company
4 March 2025 11:23
Indivior
-
Further Changes to Board of Directors
4 March 2025 07:00
Indivior
-
Indivior PLC Files 2024 Annual Report on Form 10-K
4 March 2025 07:00
Indivior
-
Total Voting Rights
3 March 2025 09:29
Indivior
-
Director/PDMR Shareholding
28 February 2025 09:43
Indivior
-
Director/PDMR Shareholding
28 February 2025 09:42
Indivior
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. This news service is operated by Digital Look Ltd. Republication or redistribution of Digital Look Ltd content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Digital Look Ltd. Please see https://www.sharecast.com/newsfeedterms/index.html for our terms and conditions.
© Digital Look Ltd 1998-2025. All rights reserved.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.